Gleason, T., Popma, J., Reardon, M., Schindler, J., Hagberg, R., Deeb, G. M., … Hughes, G. C. (2016). TCT-372 Subclavian Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. J Am Coll Cardiol, 68(18S), B152. https://doi.org/10.1016/j.jacc.2016.09.505

Gleason, Thomas, Jeffrey Popma, Michael Reardon, John Schindler, Robert Hagberg, G Michael Deeb, David Adams, John Conte, Trip Zorn, and G Chad Hughes. “TCT-372 Subclavian Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral.” J Am Coll Cardiol 68, no. 18S (November 1, 2016): B152. https://doi.org/10.1016/j.jacc.2016.09.505.

Gleason T, Popma J, Reardon M, Schindler J, Hagberg R, Deeb GM, et al. TCT-372 Subclavian Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. J Am Coll Cardiol. 2016 Nov 1;68(18S):B152.

Gleason, Thomas, et al. “TCT-372 Subclavian Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral.” J Am Coll Cardiol, vol. 68, no. 18S, Nov. 2016, p. B152. Pubmed, doi:10.1016/j.jacc.2016.09.505.

Gleason T, Popma J, Reardon M, Schindler J, Hagberg R, Deeb GM, Adams D, Conte J, Zorn T, Hughes GC. TCT-372 Subclavian Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. J Am Coll Cardiol. 2016 Nov 1;68(18S):B152.